Nephron Pharmaceuticals Corporation is a privately owned manufacturer of generic inhalation solutions headquartered in Orlando, FL. Nephron specializes in blow-fill-seal (BFS) manufacturing, a technology that allows a vial of medication to be formed, filled and sealed in a continuous process without human intervention in a sterile, enclosed area.
As an industry leader in product safety and quality, Nephron continuously pursu...
Nephron Pharmaceuticals Corporation is a privately owned manufacturer of generic inhalation solutions headquartered in Orlando, FL. Nephron specializes in blow-fill-seal (BFS) manufacturing, a technology that allows a vial of medication to be formed, filled and sealed in a continuous process without human intervention in a sterile, enclosed area.
As an industry leader in product safety and quality, Nephron continuously pursues product enhancements, such as easy to identify vial shapes, embossed lettering and color-coded packaging. In 2001, prior to FDA’s 2004 mandate, Nephron led the market in the development and release of individually wrapped and bar-coded medication. Individually wrapped and bar-coded vials are a major patient safety feature and are now standard treatments in the bedside safety practices of US hospitals.
Nephron has longstanding relationships with major drug wholesalers to distribute its products among retail pharmacies, mail order pharmacies, hospitals, home care companies, and long term care facilities. Nephron has a dedicated sales force that covers all fifty states and Puerto Rico, and has additional sales channels throughout South America, the Middle East, and Europe.
Nephron’s Orlando, FL headquarters houses its state-of-the-art BFS facility, along with its packaging, sales and distribution divisions. In total, Nephron encompasses over 300,000 square feet across three states. The company employees approximately 500 employees, but with the recent announcement of a greenfield facility located just outside of Columbia, SC Nephron expects to double in size over the next three years. Nephron is actively in search of additional partnerships with various pharmaceutical and biological companies throughout the world and is enthusiastic about plans for future growth in respiratory, ophthalmic and injectable medications.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.